Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID‐19 immunopathology: From acute diseases to chronic sequelae
Mohd Arish, Wei Qian, Harish Narasimhan, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

Regulatory T Cells (Tregs) and COVID-19: Unveiling the Mechanisms, and Therapeutic Potentialities with a Special Focus on Long COVID
Manish Dhawan, Ali A. Rabaan, Sara Alwarthan, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 699-699
Open Access | Times Cited: 39
The knowns and unknowns of long COVID-19: from mechanisms to therapeutical approaches
Roxana Gheorghiţă, Iuliana Șoldănescu, Andrei Lobiuc, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 20
Pathophysiological, immunological, and inflammatory features of long COVID
Karen Böhmwald, Benjamín Diethelm‐Varela, Linmar Rodríguez-Guilarte, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 17
Liquid biomarkers of macrophage dysregulation and circulating spike protein illustrate the biological heterogeneity in patients with post‐acute sequelae of COVID‐19
Christoph Schultheiß, Edith Willscher, Lisa Paschold, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 62
Eosinophils as potential biomarkers in respiratory viral infections
Iole Macchia, Valentina La Sorsa, Francesca Urbani, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 27
Inhibition of the mitochondrial pyruvate carrier simultaneously mitigates hyperinflammation and hyperglycemia in COVID-19
Bibo Zhu, Xiaoqin Wei, Harish Narasimhan, et al.
Science Immunology (2023) Vol. 8, Iss. 82
Open Access | Times Cited: 22
An aberrant immune–epithelial progenitor niche drives viral lung sequelae
Harish Narasimhan, In Su Cheon, Wei Qian, et al.
Nature (2024)
Closed Access | Times Cited: 10
Potential for Early Noninvasive COVID-19 Detection Using Electronic-Nose Technologies and Disease-Specific VOC Metabolic Biomarkers
A. D. Wilson, Lisa Beth Forse
Sensors (2023) Vol. 23, Iss. 6, pp. 2887-2887
Open Access | Times Cited: 20
COVID-19: Lessons Learned from Molecular and Clinical Research
Manuela Rizzi, Pier Paolo Sainaghi
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 616-616
Open Access
Outcomes of Severe Covid-19 Among Patients Who Did and Did Not Receive Tocilizumab: A Two-year Prospective Cohort Study
Branko Beronja, Tatjana Gazibara, Olja Stevanović, et al.
(2025)
Closed Access
Post-COVID-19 sequelae are associated with sustained SARS-CoV-2-specific CD4+ immune responses
Chiara Venegoni, Davide Raineri, Camilla Barbero Mazzucca, et al.
International Immunopharmacology (2025) Vol. 148, pp. 114103-114103
Closed Access
Bronchoalveolar lavage single-cell transcriptomics reveals immune dysregulations driving COVID-19 severity
Njinju Asaba Clinton, Razieh Bitazar, Patrick Labonté, et al.
PLoS ONE (2025) Vol. 20, Iss. 2, pp. e0309880-e0309880
Open Access
Nanoparticles of Natural Product-derived Medicines: Beyond the Pandemic
Yedi Herdiana
Heliyon (2025) Vol. 11, Iss. 4, pp. e42739-e42739
Open Access
Brain Leukocytes as the Potential Therapeutic Target for Post-COVID-19 Brain Fog
Itsuro Kazama
Neurochemical Research (2023) Vol. 48, Iss. 8, pp. 2345-2349
Open Access | Times Cited: 13
SARS-CoV-2: A Glance at the Innate Immune Response Elicited by Infection and Vaccination
Nicola Manfrini, Samuele Notarbartolo, Renata Grifantini, et al.
Antibodies (2024) Vol. 13, Iss. 1, pp. 13-13
Open Access | Times Cited: 4
Immunobiology of COVID-19: Mechanistic and therapeutic insights from animal models
Hong‐Yi Zheng, Tian‐Zhang Song, Yong‐Tang Zheng
动物学研究 (2024) Vol. 45, Iss. 4, pp. 747-766
Open Access | Times Cited: 4
Unraveling the enigma of long COVID: novel aspects in pathogenesis, diagnosis, and treatment protocols
Abdul Mannan Baig, Sandy Rosko, B.R. Jaeger, et al.
Inflammopharmacology (2024) Vol. 32, Iss. 4, pp. 2075-2090
Closed Access | Times Cited: 4
Aggregate Index of Systemic Inflammation (AISI), Disease Severity, and Mortality in COVID-19: A Systematic Review and Meta-Analysis
Angelo Zinellu, Panagiotis Paliogiannis, Arduino A. Mangoni
Journal of Clinical Medicine (2023) Vol. 12, Iss. 14, pp. 4584-4584
Open Access | Times Cited: 11
Postinfectious Pulmonary Complications: Establishing Research Priorities to Advance the Field: An Official American Thoracic Society Workshop Report
Sara C. Auld, Ajay Sheshadri, Jennifer Alexander‐Brett, et al.
Annals of the American Thoracic Society (2024) Vol. 21, Iss. 9, pp. 1219-1237
Closed Access | Times Cited: 3
Molecular and immune signatures, and pathological trajectories of fatal COVID‐19 lungs defined by in situ spatial single‐cell transcriptome analysis
Arun Das, Wen Meng, Zhentao Liu, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 8
Open Access | Times Cited: 9
A 5-Lipoxygenase Inhibitor, Zileuton, Modulates Host Immune Responses and Improves Lung Function in a Model of Severe Acute Respiratory Syndrome (SARS) Induced by Betacoronavirus
Rafaela das Dores Pereira, Rayane Aparecida Nonato Rabelo, Natália Fernanda de Melo Oliveira, et al.
Viruses (2023) Vol. 15, Iss. 10, pp. 2049-2049
Open Access | Times Cited: 7
A Pictorial Essay Describing the CT Imaging Features of COVID-19 Cases throughout the Pandemic with a Special Focus on Lung Manifestations and Extrapulmonary Vascular Abdominal Complications
Barbara Brogna, Elio Bignardi, A. Megliola, et al.
Biomedicines (2023) Vol. 11, Iss. 8, pp. 2113-2113
Open Access | Times Cited: 5
Proximal immune-epithelial progenitor interactions drive chronic tissue sequelae post COVID-19
Harish Narasimhan, In Su Cheon, Wei Qian, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 5
Control of complement-induced inflammatory responses to SARS-CoV-2 infection by anti-SARS-CoV-2 antibodies
Marta Bermejo‐Jambrina, Lieve E. H. van der Donk, John L. van Hamme, et al.
The EMBO Journal (2024) Vol. 43, Iss. 7, pp. 1135-1163
Open Access | Times Cited: 1
Recent advances in health biotechnology during pandemic
Selcen Arı Yuka
Sigma Journal of Engineering and Natural Sciences – Sigma Mühendislik ve Fen Bilimleri Dergisi (2023)
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top